This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Aouida, M. Articles by Ramotar, D. Search for Related Content PubMed PubMed Citation Articles by Aouida, M. Articles by Ramotar, D.

A Genome-Wide Screen in Saccharomyces cerevisiae Reveals Altered Transport As a Mechanism of Resistance to the Anticancer Drug Bleomycin

¹ University of Montreal, Guy-Bernier Research Centre, Montreal, Quebec, Canada and ² Swiss Federal Institute of Technology Zurich, Institute of Biochemistry, Zurich, Switzerland

The potent DNA damaging agent bleomycin (BLM) is highly effective for treating various cancers, although, in certain individuals, the development of cellular resistance to the drug can severely diminish its antineoplastic properties. We performed two independent genome-wide screens using a Saccharomyces cerevisiae mutant collection to isolate variants exhibiting either sensitivity or resistance to BLM. This procedure reproducibly identified a relatively large collection of 231 BLM-hypersensitive mutants, representing genes belonging to diverse functional groups. In contrast, only five BLM-resistant mutants could be recovered by our screens. Among these latter mutants, three were deleted for genes involved in plasma membrane transport, including the L-carnitine transporter Agp2, as well as the kinases Ptk2 and Sky1, which are involved in regulating polyamine transport. We further showed that Agp2 acts as a transporter of BLM and that overexpression of this transporter significantly enhances BLM-induced cell killing. Our data strongly implicate membrane transport as a key determinant in BLM resistance in yeast. This finding is critical, given that very little is known about BLM transport in human cells. Indeed, characterization of analogous mechanisms in humans may ultimately lead to enhancement of the antitumor properties of BLM.

This article has been cited by other articles:

				J. Chen, M. K. Ghorai, G. Kenney, and J. Stubbe Mechanistic studies on bleomycin-mediated DNA damage: multiple binding modes can result in double-stranded DNA cleavage Nucleic Acids Res., June 1, 2008; 36(11): 3781 - 3790. [Abstract] [Full Text] [PDF]

				K. Dawson, W. M. Toone, N. Jones, and C. R. M. Wilkinson Loss of Regulators of Vacuolar ATPase Function and Ceramide Synthesis Results in Multidrug Sensitivity in Schizosaccharomyces pombe Eukaryot. Cell, June 1, 2008; 7(6): 926 - 937. [Abstract] [Full Text] [PDF]

				E. D. Strome, X. Wu, M. Kimmel, and S. E. Plon Heterozygous Screen in Saccharomyces cerevisiae Identifies Dosage-Sensitive Genes That Affect Chromosome Stability Genetics, March 1, 2008; 178(3): 1193 - 1207. [Abstract] [Full Text] [PDF]

				B. L. Pike and J. Heierhorst Mdt1 Facilitates Efficient Repair of Blocked DNA Double-Strand Breaks and Recombinational Maintenance of Telomeres Mol. Cell. Biol., September 15, 2007; 27(18): 6532 - 6545. [Abstract] [Full Text] [PDF]

				H. Cai, S. Kauffman, F. Naider, and J. M. Becker Genomewide Screen Reveals a Wide Regulatory Network for Di/Tripeptide Utilization in Saccharomyces cerevisiae Genetics, March 1, 2006; 172(3): 1459 - 1476. [Abstract] [Full Text] [PDF]

				K. Hellauer, G. Lesage, A.-M. Sdicu, and B. Turcotte Large-Scale Analysis of Genes that Alter Sensitivity to the Anticancer Drug Tirapazamine in Saccharomyces cerevisiae Mol. Pharmacol., November 1, 2005; 68(5): 1365 - 1375. [Abstract] [Full Text] [PDF]

				G. Thornton, C. R. M. Wilkinson, W. M. Toone, and N. Jones A novel pathway determining multidrug sensitivity in Schizosaccharomyces pombe Genes Cells, October 1, 2005; 10(10): 941 - 951. [Abstract] [Full Text] [PDF]

				R.-Y. Huang, M. Eddy, M. Vujcic, and D. Kowalski Genome-Wide Screen Identifies Genes Whose Inactivation Confer Resistance to Cisplatin in Saccharomyces cerevisiae Cancer Res., July 1, 2005; 65(13): 5890 - 5897. [Abstract] [Full Text] [PDF]

				M. Aouida, A. Leduc, R. Poulin, and D. Ramotar AGP2 Encodes the Major Permease for High Affinity Polyamine Import in Saccharomyces cerevisiae J. Biol. Chem., June 24, 2005; 280(25): 24267 - 24276. [Abstract] [Full Text] [PDF]

				G. G. Perrone, C. M. Grant, and I. W. Dawes Genetic and Environmental Factors Influencing Glutathione Homeostasis in Saccharomyces cerevisiae Mol. Biol. Cell, January 1, 2005; 16(1): 218 - 230. [Abstract] [Full Text] [PDF]